Author:
Ciaramellano Francesca,Fanti Federico,Scipioni Lucia,Maccarrone Mauro,Oddi Sergio
Reference50 articles.
1. Pacher P, Bátkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58:389. https://doi.org/10.1124/PR.58.3.2
2. Hu W-R, Lian Y-F, Peng L-X, Lei J-J, Deng C-C, Xu M, Feng Q-S, Chen L-Z, Bei J-X, Zeng Y-X (2014) Monoacylglycerol lipase promotes metastases in nasopharyngeal carcinoma. Int J Clin Exp Pathol 7:3704–3713
3. Gong X, Zheng X, Huang Y, Song W, Chen G, Chen T (2022) Monoacylglycerol lipase (MAGL) inhibition impedes the osteosarcoma progression by regulating epithelial mesenchymal transition. Tohoku J Exp Med 256:19–26. https://doi.org/10.1620/TJEM.256.19
4. Kokona D, Spyridakos D, Tzatzarakis M, Papadogkonaki S, Filidou E, Arvanitidis KI, Kolios G, Lamani M, Makriyannis A, Malamas MS et al (2021) The endocannabinoid 2-arachidonoylglycerol and dual ABHD6/MAGL enzyme inhibitors display neuroprotective and anti-inflammatory actions in the in vivo retinal model of AMPA excitotoxicity. Neuropharmacology 185:108450. https://doi.org/10.1016/J.NEUROPHARM.2021.108450
5. Deng H, van der Stelt M (2018) Chemical tools to modulate 2-arachidonoylglycerol biosynthesis. Biotechnol Appl Biochem 65:9–15. https://doi.org/10.1002/bab.1568
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献